SOPHIA’S INITIAL TREATMENT

Hypothetical patient profile. May not be
representative of all patients.

  • TRANSCRIPT

    CHARLOTTE: Sophia was started on a few medications. She seemed to be getting better at first.

    ON-SCREEN TEXT: Sophia*

    ON-SCREEN TEXT: * Hypothetical patient profile. May not be representative of all patients.

    SOPHIA: I did feel better most of the time. I had to take pills - that was hard - but I guess I’m used to it now.

    ON-SCREEN TEXT: Sophia’s initial treatment plan*: Hydroxychloroquine: 200 mg/day; Prednisone: 7.5 mg/day.

    ON-SCREEN TEXT: * Hypothetical patient profile. May not be representative of all patients.

    CHARLOTTE: She was experiencing leg pain and sometimes her rash would get really bad and she would be so tired. She was able to make it to more of her extra-curricular activities, but she was still missing school too often.

    ON-SCREEN TEXT: Sophia’s lab values*: Positive antinuclear antibodies (ANA): ≥1:80; Proteinuria: ≥0.5 mg/24 hours.

    ON-SCREEN TEXT: * Hypothetical patient profile. May not be representative of all patients.

    SOPHIA: I actually wanted to be at school more, but I was having such a hard time concentrating. I really missed seeing my friends every day.

    ON-SCREEN TEXT: Trademarks owned or licensed by GSK. BELVID210028 September 2021.

You may also like

SEE SOPHIA’S DIAGNOSIS STORY
LEARN ABOUT SOPHIA’S
BENLYSTA TREATMENT

Hypothetical patient profile. May not be
representative of all patients.